Compare BAL PHARMA with DIL LIMITED - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs FERMENTA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA FERMENTA BIOTECH BAL PHARMA/
FERMENTA BIOTECH
 
P/E (TTM) x 51.0 29.1 175.3% View Chart
P/BV x 2.7 2.5 109.9% View Chart
Dividend Yield % 1.0 0.8 121.4%  

Financials

 BAL PHARMA   FERMENTA BIOTECH
EQUITY SHARE DATA
    BAL PHARMA
Mar-21
FERMENTA BIOTECH
Mar-21
BAL PHARMA/
FERMENTA BIOTECH
5-Yr Chart
Click to enlarge
High Rs73442 16.5%   
Low Rs29218 13.1%   
Sales per share (Unadj.) Rs169.0130.8 129.3%  
Earnings per share (Unadj.) Rs3.214.7 21.6%  
Cash flow per share (Unadj.) Rs9.621.8 44.1%  
Dividends per share (Unadj.) Rs1.002.50 40.0%  
Avg Dividend yield %2.00.8 259.8%  
Book value per share (Unadj.) Rs35.5120.8 29.4%  
Shares outstanding (eoy) m14.8228.85 51.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.32.5 11.9%   
Avg P/E ratio x16.022.4 71.4%  
P/CF ratio (eoy) x5.315.1 34.9%  
Price / Book Value ratio x1.42.7 52.4%  
Dividend payout %31.517.0 185.5%   
Avg Mkt Cap Rs m7539,520 7.9%   
No. of employees `000NANA-   
Total wages/salary Rs m419582 71.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2,5053,773 66.4%  
Other income Rs m1184 13.6%   
Total revenues Rs m2,5173,857 65.3%   
Gross profit Rs m246826 29.8%  
Depreciation Rs m95203 46.9%   
Interest Rs m122190 64.0%   
Profit before tax Rs m41516 7.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-691 -6.7%   
Profit after tax Rs m47425 11.1%  
Gross profit margin %9.821.9 44.9%  
Effective tax rate %-14.917.6 -84.3%   
Net profit margin %1.911.3 16.7%  
BALANCE SHEET DATA
Current assets Rs m1,6413,096 53.0%   
Current liabilities Rs m1,5252,093 72.9%   
Net working cap to sales %4.626.6 17.4%  
Current ratio x1.11.5 72.8%  
Inventory Days Days1183 12.9%  
Debtors Days Days979658 148.8%  
Net fixed assets Rs m7593,371 22.5%   
Share capital Rs m148144 102.8%   
"Free" reserves Rs m3783,342 11.3%   
Net worth Rs m5263,486 15.1%   
Long term debt Rs m2391,104 21.7%   
Total assets Rs m2,4016,468 37.1%  
Interest coverage x1.33.7 36.0%   
Debt to equity ratio x0.50.3 143.5%  
Sales to assets ratio x1.00.6 178.9%   
Return on assets %7.09.5 73.9%  
Return on equity %9.012.2 73.4%  
Return on capital %21.215.4 138.0%  
Exports to sales %60.00-   
Imports to sales %22.70-   
Exports (fob) Rs m1,504NA-   
Imports (cif) Rs m568NA-   
Fx inflow Rs m1,5042,551 59.0%   
Fx outflow Rs m5861,035 56.6%   
Net fx Rs m9181,516 60.5%   
CASH FLOW
From Operations Rs m218626 34.8%  
From Investments Rs m-50-416 12.0%  
From Financial Activity Rs m-166-11 1,455.1%  
Net Cashflow Rs m2205 0.8%  

Share Holding

Indian Promoters % 42.5 59.4 71.4%  
Foreign collaborators % 4.4 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 1,500.0%  
FIIs % 0.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 53.1 40.6 131.0%  
Shareholders   16,319 18,399 88.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   ALPA LAB  WOCKHARDT  ROOPA INDUSTRIES  BIOFIL CHEMICALS  VINEET LABORATORIES  



Today's Market

Sensex Jumps 500 Points, Nifty Above 17,100; Metal & Automobile Stocks Rally(10:30 am)

Asian stock markets swung between positive and negative territory as investors remained cautious about a new virus strain and US monetary policy moves over inflation.

Related Views on News

FERMENTA BIOTECH 2020-21 Annual Report Analysis (Annual Result Update)

Oct 29, 2021 | Updated on Oct 29, 2021

Here's an analysis of the annual report of FERMENTA BIOTECH for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of FERMENTA BIOTECH. Also includes updates on the valuation of FERMENTA BIOTECH.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BAL PHARMA SHARE PRICE


Dec 1, 2021 11:44 AM

TRACK BAL PHARMA

  • Track your investment in BAL PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BAL PHARMA WITH

MARKET STATS